ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2295

Is There Peripheral Large Nerve Involvement in Fibromyalgia?  a Systematic EMG / Nerve Conduction Study Evaluation of 55 Consecutive FM Patients

Xavier J. Caro, Robert G. Galbraith and Earl F. Winter, Southern California Fibromyalgia Research and Treatment Center, Northridge, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: electromyography, Fibromyalgia and neurologic involvement, Pathophysiology

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

     Background/Purpose: Several recent reports have implicated peripheral small fiber neuropathy (SFN) as a significant contributing factor to the pain seen in fibromyalgia (FM).  Large fiber neuropathy (LFN) in this disorder has not been extensively described, however. Therefore, we retrospectively examined electromyographic (EMG) and nerve conduction study (NCS) data (collectively, “EDX”) on a cohort of FM patients and controls for LFN, and clinically correlated our findings. 

    Methods:   We reviewed clinical and EDX data from 100 consecutive patients, meeting 1990 ACR FM criteria, for study inclusion / exclusion.  Subjects with a clinical disorder known to produce LFN (e.g., diabetes, Vitamin B-12 deficiency, familial neuropathy, Sjögren’s syndrome, etc.) were excluded.  Those with FM + RA were allowed.  EDX findings from 30 “FM Only” (27 Caucasian; 23 female; mean age 59, range 21 – 90 yrs.), 25 FM + RA (20 Caucasian; 23 female; mean age 57, range 26 – 84 yrs.), and 14 control subjects with No FM & No RA (mostly incidental evaluation for carpal tunnel syndrome) were compared.  

     Results:  All 55 FM subjects in this cohort had EDX findings of LFN (Figure), with most having a sensorimotor polyneuropathy (90%), which was demyelinating only, in 22%, axonal only, in 12%, and mixed demyelinating / axonal, in 66%.  A sensorimotor polyneuropathy was seen in only 7% of control patients (P < 0.0001).  NCS features in FM Only included temporal dispersion, prolonged duration, abnormal F-wave, or carpal tunnel syndrome in 28%, 10%, 21%, and 24% respectively.  EMG in FM Only showed findings of lower extremity axonal denervation, thought most likely due to a polyneuropathy, in 61%.  Clinical correlation in the FM Only group showed a significant association between EMG denervation and proximal muscle weakness (P < 0.005).  EDX findings meeting published criteria for, at least, “possible” chronic inflammatory demyelinating polyneuropathy (CIDP) were seen in 41% of FM Only subjects, but in no control subjects (P<0.003).  Calf epidermal nerve fiber density (ENFD) was reduced to ≤ 6.5 fibers / mm in 53% and ≤ 7.0 fibers / mm in 63% of FM Only subjects.

     Conclusion:  All FM subjects in our cohort had evidence of LFN, suggesting that these lesions participate in FM symptomatology.  “FM Only” and FM + RA participants did not demonstrate any major between-group differences in EDX findings.  EDX appeared to compliment ENFD determinations in defining the peripheral neuropathology of FM.  These EDX findings probably hold important implications for the better understanding and treatment of this painful disorder.

Macintosh HD:Users:xaviercaro:Desktop:2015 ACR Abstract Figure 2015.png

LFN in FM: A vs. C (P value) <0.0001, B vs. C <0.0001, D vs. F <0.0001, E vs. F = 0.0001, G vs. I = 0.02, H vs. I = 0.01, J vs. L = 0.003, K vs. L = 0.002, M vs. O = 0.03, N vs. O = 0.01, S vs. U = 0.08, T vs. U = 0.01.  (Fischer’s Exact Test, 2 tailed) Other comparisons were NS.  * Indicates 1% for illustration purposes; actual value = 0%.


Disclosure: X. J. Caro, None; R. G. Galbraith, None; E. F. Winter, None.

To cite this abstract in AMA style:

Caro XJ, Galbraith RG, Winter EF. Is There Peripheral Large Nerve Involvement in Fibromyalgia?  a Systematic EMG / Nerve Conduction Study Evaluation of 55 Consecutive FM Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/is-there-peripheral-large-nerve-involvement-in-fibromyalgia-a-systematic-emg-nerve-conduction-study-evaluation-of-55-consecutive-fm-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-there-peripheral-large-nerve-involvement-in-fibromyalgia-a-systematic-emg-nerve-conduction-study-evaluation-of-55-consecutive-fm-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology